Drug Information Related to Lapatinib
Back
01. Research and Markets: Renal Cell Carcinoma and Multiple Myeloma ......
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c42593) has announced the addition of Financial Markets Research: ASCO Review Part I - A Summary of Highlights Presented at the ASCO 2006 Annual Meeting to their offering.
...
02. GSK aggressively pursues innovation | Food & Drug Packaging | Find...
GlaxoSmithKline may be No. 2 on our list based on overall pharmaceutical sales (for the second year running), but the company refuses to take a back seat when it comes to developing innovative products and packages.
...
03. New Data Offers Insights Into the Potential Role for TYKERB® in Non ....
TYKERB Demonstrates Activity in Combination with Other Targeted Therapies and as Monotherapy Across A Range of Breast Cancer Settings
...
04. Experimental drug slows HER2-positive cancer | OB/GYN News | Find ......
ATLANTA -- The investigational drug lapatinib slows disease progression in women with advanced or metastatic HER2-positive breast cancer that has become resistant to targeted therapy with trastuzumab.
...
05. The development of epidermal growth factor receptor-targeted therapies...
Epidermal growth factor receptor and tumour biology
In health, normal cellular growth and function is reliant on the
maintenance of a complex equilibrium of stimulatory and inhibitory
cellular signalling. In many malignant diseases this equilibrium is
lost, re...
06. American drug index 2008, 52d ed. - Free Online Library
9781574392715
American drug index 2008, 52d ed.
Facts & Comparisons
2007
1129 pages
$84.95
Hardcover
RS51
The 52nd edition of this reference text provides information about
the identification, explanation, and correlation of the many
ph...
07. The Top 20 Cancer Therapy Brands Are Forecast to Experience 144 ......
DUBLIN, Ireland -- Research and Markets
(http://www.researchandmarkets.com/reports/c63509) has announced the
addition of Commercial Insight: Top 20 Cancer Therapy Brands - Sales of
Targeted Therapies Overtake Cytotoxics in 2006 to their offering.
Sales of the ...
08. Array BioPharma Appoints Dr. Neil Spector to Its Scientific Advisory ....
New Member Brings Strong Oncology Expertise
BOULDER, Colo. -- Array BioPharma Inc. (NASDAQ: ARRY) today
announced the appointment of Neil Spector, M.D., to its Scientific
Advisory Board. Dr. Spector will focus on helping Array in the
development of its cancer ...
09. Targeted therapy in cancer in the 21st century. - Free Online Library...
Therapies targeting signalling pathways have become the hallmark of
advances in cancer therapy in the 21st century. Most therapies target
circulating ligands, extracellular receptor domains of transmembrane
receptor tyrosine kinases (RTKs), intracellular ATP-bind...
10. HER2-directed therapies. - Free Online Library
Introduction
The human epidermal growth factor receptor (HER)2 (neu, c-erbB2) is
a 185-Kd protein encoded on chromosome 17q21. It belongs to a family of
four transmembrane tyrosine kinase cell surface receptors which also
includes HER1, HER3 and HER4. Each has...
11. Research and Markets: Renal Cell Carcinoma and Multiple Myeloma ......
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c42593) has announced the addition of Financial Markets Research: ASCO ASCO - Advanced System Concepts OfficeASCO - Advanced Systems and Concepts Office (US DTRA)ASCO - American Societ...
12. What is the next step for adjuvant breast cancer chemotherapy followin...
Introduction
Breast cancer is the second most common cause of cancer death in
females in the UK, accounting for 40.5 deaths per 100,000 women. In
2004, there were 44,659 new cases of breast cancer diagnosed in the UK
and over the period 1980-2004 the incidence...
13. Reuters Health News Summary - Free Online Library
Following is a summary of health news briefs compiled from
stories that have run separately and are available in full on
the file.
Group says heart and stroke deaths fall in U.S. WASHINGTON (Reuters) - Death rates from heart disease and
stroke are falling in the Un...
14. Four Inflammatory Breast Cancer Signs & Six FAQs
Nearly 200,000 women are diagnosed with breast cancer each year and over 40,000 will die from it. There are seven different types of breast cancer, some more severe and with a lower survival rate than others.One breast cancer type called Inflammatory breast cancer, or...
15. 274 Different Pipelines Molecular Targeted Cancer Therapies Have Been ...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c44205) has announced the addition of Pipeline/Commercial Insight: Molecular Targeted Cancer Therapies - More Drugs on the Market, More Targets in the Pipeline to their offering Cance...
